
    
      The ZEBRE (ZEBinixÂ® Retention rate in epilepsy in Elderly patients) study is a prospective,
      multicenter, descriptive study. ESL will be prescribed according to the usual care. Posology
      and method of administration of ESL are defined by the summary of product characteristics.
    
  